0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.28%
Positive revenue growth while 0259.HK is negative. John Neff might see a notable competitive edge here.
8.80%
Positive gross profit growth while 0259.HK is negative. John Neff would see a clear operational edge over the competitor.
85.33%
Positive EBIT growth while 0259.HK is negative. John Neff might see a substantial edge in operational management.
85.33%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
87.44%
Net income growth 1.25-1.5x 0259.HK's 75.02%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
62.43%
EPS growth at 75-90% of 0259.HK's 79.31%. Bill Ackman would push for improved profitability or share repurchases to catch up.
62.43%
Diluted EPS growth at 75-90% of 0259.HK's 79.31%. Bill Ackman would expect further improvements in net income or share count reduction.
15.43%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
15.37%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Dividend reduction while 0259.HK stands at 0.10%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-698.01%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-308.72%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
11795.63%
10Y revenue/share CAGR above 1.5x 0259.HK's 111.59%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-12.09%
Negative 5Y CAGR while 0259.HK stands at 24.02%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-5.77%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-9561.15%
Negative 10Y OCF/share CAGR while 0259.HK stands at 60.15%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-664.88%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1361.38%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
233.13%
Below 50% of 0259.HK's 655.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
384.15%
Positive 5Y CAGR while 0259.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-14.85%
Negative 3Y CAGR while 0259.HK is 207.87%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
149.37%
Positive 5Y equity/share CAGR while 0259.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
62.96%
3Y equity/share CAGR above 1.5x 0259.HK's 39.29%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 700.80%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0259.HK invests at 60.17%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-18.74%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
30.58%
We show growth while 0259.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.55%
Negative asset growth while 0259.HK invests at 4.37%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.59%
Under 50% of 0259.HK's 11.61%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-99.86%
We’re deleveraging while 0259.HK stands at 114.39%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-35.78%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-46.41%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.